Podcast appearances and mentions of rebecca siegel

This week, author Rebecca Siegel offers media literacy advice and discusses her book Loch Ness Uncovered: Media, Misinformation, and the Greatest Monster Hoax of All Time, an extensively researched, myth-busting account of the world’s most famous monster hoax—the Loch Ness Monster—and a cautionary tale on the dangers of misinformation. This conversation originally took place May [...]

This week, author Rebecca Siegel offers media literacy advice and discusses her book Loch Ness Uncovered: Media, Misinformation, and the Greatest Monster Hoax of All Time, an extensively researched, myth-busting account of the world's most famous monster hoax—the Loch Ness Monster—and a cautionary tale on the dangers of misinformation. This conversation originally took place May 19, 2024 and was recorded live at the American Writers Festival.AWM PODCAST NETWORK HOMEMore about Loch Ness Uncovered:In 1934, a man was walking by a lake in the Scottish Highlands when he saw a long-necked creature swimming in the water. He grabbed his camera and snapped a photo. When the photo landed on the front page of the Daily Mail, it shattered the belief that paranormal creatures were pure fiction. But amid the monster-hunting craze, complex conspiracies soon emerged. The Loch Ness Monster became more than a mysterious sea creature—it became a phenomenon that caused people to question their assumptions and dig for the truth.Meticulously researched through primary sources and in-depth interviews with key figures, Loch Ness Uncovered is the fascinating true story of the conspiracy that sparked intrigue worldwide. Complete with archival images, an engaging narrative, and a guide to media literacy, here is a nonfiction book that will transport young readers to the thrilling world of monster mania.REBECCA SIEGEL has worked in children's publishing for 18 years. Three of her books have received Starred Reviews in Booklist, including To Fly Among the Stars (Scholastic 2020), which was also named a Mighty Girl's Book of the Year, and one of the National Science Teaching Association's Outstanding Science Trade Books for Students. Another recent title, Mayflower (Quarto 2020) was named a 2021 EUREKA! Children's Honor Book. Rebecca has two books publishing in 2024: Loch Ness Uncovered (Astra Young Readers) and The United States Book (Welbeck). Rebecca lives in the Chicago suburbs with her husband and two daughters.

Yale School of Medicine's Veda Giri, the American Cancer Society's Rebecca Siegel and the National Cancer Institute's Steven Rosenberg join Washington Post Live to discuss what is driving higher cancer rates in young people, how the disease is impacting under-resourced communities and the new cutting-edge immunotherapy treatments that aim to transform the cancer care landscape. Conversation recorded on Wednesday, October 16, 2024.

On March 23, Dr. Marianne Ritchie chatted with Rebecca Siegel, Scientific Director of Surveillance Research at American Cancer Society, about the ACS annual report that provides current statistics on occurrence, death rate, and survival for various cancers. The report also estimates the number of new cases for the coming year, as well as information on cancer symptoms, risk factors, early detection, and treatment. Rebecca Siegel is the lead author of this impressive report.For more information, visit: https://yourradiodoctor.net/episode-197-cancer-facts-and-figures/

Dr. Rebecca Siegel, senior scientific director, surveillance research at the American Cancer Society, joins Lisa Dent to talk about the organization's annual report on cancer trends that revealed 2 millions new diagnoses for the first time and what that means for men and women. Follow The Lisa Dent Show on Twitter:Follow @LisaDentSpeaksFollow @SteveBertrand Follow @kpowell720 […]

In our latest episode of our B-Side series, we talk about how trauma shapes the brain. Dr. Rebecca Siegel, M.D. also joins us to talk about how brain elasticity and plant medicine intersect. Article and website mentioned:7 ways childhood adversity changes a child's brainAces Too High

Dr. Rebecca Siegel is a clinical psychiatrist and author of the newly published book, The Brain on Cannabis: What You Should Know about Recreational and Medical Marijuana, a comprehensive and myth-busting guide on marijuana use and its effects on the brain. The book also addresses how to effectively talk to young people about recreational marijuana use based on her work as a physician who specializes in the assessment and treatment of anxiety, mood disorders, and ADHD. In the book, Dr. Siegel reviews the full spectrum of marijuana's benefits and risks and debunks myths surrounding cannabis and explores the promises and risks of its many therapeutic possibilities. She thoughtfully investigates the potential downsides of cannabis, particularly with regards to brain health referencing The Amen Clinics' brain SPECT imaging studies. Siegel opens each chapter with an overview of contradictory marijuana myths (i.e., “The Myth of Harmlessness: Teens won't be adversely affected by marijuana use / The Myth of Harmfulness: My teen will be irreparably harmed by marijuana use in the short-term and the long-term”), and concludes with her observations as a doctor, as well a conclusion of “What We Know for Sure.” https://rebeccasiegelmd.com/ Bryan Buckley, President and CEO As a Special Operations Team Commander with Marine Raiders, Bryan led multiple teams in deployments to Operation Enduring Freedom-Trans Sahara (Africa), South East Asia, and Operation Enduring Freedom-Afghanistan (Helmand Province). Developed rapport with numerous host nation forces, enhanced capability and capacity within the host nation units, and briefed US Ambassadors. Additionally, he led a 20 man Marine Raider Team to Afghanistan that mentored, trained and conducted over 40 combat operations with an Afghan Special Operations Battalion. Bryan also deployed twice to Operation Iraqi Freedom with Marine Infantry and Marine Reconnaissance. Awarded Bronze Star Medal with “Combat Distinguishing Device” for Heroic Service Awarded the Purple Heart Medal for wounds received during combat operations About Battle Brothers Foundation: Founded in 2016 by U.S. Special Operations Marine Raider, Bryan Buckley, Battle Brothers Foundation is a 501c3 charitable organization that empowers veterans through community-based personal development, economic upward mobility, and progressive medical treatments to better their lives and the lives of their families. The organization is currently looking for people striving to make a difference in a veteran's life by pledging a donation or joining their team of volunteers. About HVGC: HVGC was founded by three United States Special Operations Veterans (Marine Raiders). Since its inception, HVGC has been in discussions with some of the cannabis industry's top researchers and has developed a veteran based protocol to effectively prove the benefits of medical cannabis. HVGC is developing medical cannabis-based solutions to address symptoms of PTS, the opioid and suicide epidemic that plague U.S. veterans and society as a whole. In coordination with Battle Brothers Foundation, 100% of HVGC's profits goes toward medical cannabis research. https://hvgcompany.com/ https://battlebrothersfoundation.org/ ************ Your Host - Brad Richard Scars & Stripes Coffee: https://www.ss.coffee/bradrichard YouTube: https://tinyurl.com/y7uzojak Manat50 School: https://brad-s-school-4d92.thinkific.com Website: https://www.bradrichard.net --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/manat50/message Support this podcast: https://anchor.fm/manat50/support

Today, we're talking about cannabis. Join me in conversation with Dr. Rebecca Siegel about cannabis and brain health as well as the impact specifically on the adolescent brain. Sponsors Beam: shopbeam.com slashHUMANS Slumberkins: Use code HUMANS at checkout for 15% Off Your First Order at www.Slumberkins.com Camp Galileo: Go to GALILEO-CAMPS.COM and use the code FUNSUMMER2022 to get $100 off camp.Cozy Earth: 35% off sitewide at Cozy Earth with code HUMANS Produced by Dear Media

The Brain on Cannabis: What You Should Know About Recreational and Medical Marijuana (Amen Clinic Library) with Rebecca Siegel today on Concierge For Better Living only on Cannabis Radio. From the Amen Clinics, America's frontline resource for brain health and treatment of brain injury comes the most comprehensive and myth-busting guide yet on marijuana use and its effects on the brain—including how to effectively talk to young people about recreational marijuana use. For more than 25 years, the renowned Amen Clinics has been a frontline resource for brain health. NOW they TACKLE all your questions about how marijuana affects your brain—and the brain of your child.

Dr. Rebecca Siegel is a clinical psychiatrist and author of the newly published book, The Brain on Cannabis: What You Should Know about Recreational and Medical Marijuana. In her book, Dr. Siegel explores marijuana's therapeutic possibilities and its effects on the brain, based on her own work with patients and in her study of brain MRIs. During this podcast-exclusive interview, we dive deeper with Dr. Siegel into marijuana's healing effects and her patient experience with it. We answer all your burning questions (pun intended) about marijuana use and how it effects the brain. In this interview you'll hear more about marijuana's medical benefits, any downsides, what conditions it can help with, and why it affects some people differently than others. If you want to learn more about the brain on marijuana, tune in! Remember to follow womendotcom on instagram and subscribe to The Women.com Podcast for more exclusive interviews.

On this episode of Let's be Blunt Montel talks with Dr Rebecca Siegel, the author of the newly published book, The Brain on Cannabis: What You Should Know about Recreational and Medical Marijuana. Dr Siegel is a clinical psychiatrist specializing in adult, child and adolescent psychotherapy and psychopharmacology. Her practice includes the evaluation and treatment of depression, mood disorders, attention deficit disorders, learning disabilities, Aspergers and autism spectrum disorder and she is a licensed prescriber of medical cannabis in New York State. Her book inlcudes tip on how to effectively talk to young people about recreational cannabis as well as addressing common myths surroundig cannabis. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Patient curiosity (and desperation) has been the driving force behind physicians opening up to the idea of cannabis as a medicine. Dr. Rebecca Siegel, Clinical Psychiatrist & Author of “The Brain on Cannabis: What you should know about Recreational & Medical Marijuana”, joins us to discuss her perspective on cannabis and how her team is using Functional MRI scans to study the effects of cannabis.   LINK: Periodic Effects Youtube Channel   LINK: Schedule 1-on-1 Consulting Call w/ Wayne *read all details for 1-on-1 calls in this calendar link   LINK: Contact Periodic Effects Podcast

For a long time, Dr. Rebecca Siegel never thought about recommending cannabis for patients. But when her patients started telling her about the way cannabis improved their health issues, the psychiatrist started to do her own research — and the results she found were so compelling that she wrote a book about it. Dr. Rebecca's book, The Brain on Cannabis: What You Should Know about Recreational and Medical Marijuana, is a comprehensive and myth-busting guide on marijuana use and its effects on the brain. On the pod, she talks to Jon about why she wrote the book, and some myths she wants to dispel about the drug. She also recommends some strategies for talking to your kids about cannabis in an educational way.

How does cannabis affect the brains development?   Dr Rebecca Siegel a board certified Adult, Child & Adolescent Psychiatrist at the Amen Clinics in New York and author of The Brain On Cannabis uses prescribes cannabis to her patients.  She joins Justin Benton  Janet Benton Gaillard  and Dan Humiston to share stories from her work at the front-line of treating patients with cannabis.  She discusses her new book and provides both optimism and caution for cannabis medical and recreational benefits.   Join the Miracle Plant live on Clubhouse every Saturday morning Produced by PodConX       #HealTheWorld #3billionby2025 Miracle Plant - https://podconx.com/podcasts/miracle-plantMiracle Plant - www.themiracleplant.orgJustin Benton - https://podconx.com/guests/justin-bentonJanet Benton Gaillard - https://podconx.com/guests/janet-benton-gaillardDan Humiston - https://podconx.com/guests/dan-humistonDr Rebecca Siegel - https://podconx.com/guests/rebecca-siegelDr Rebecca Siegel Website - https://drrebeccasiegel.com/Amen Clinics - https://www.amenclinics.com/team/rebecca-siegel-md/The Brain on Cannabis - https://www.amazon.com/Brain-Cannabis-Recreational-Medical-Marijuana/dp/0806540869/ref=sr_1_1?qid=1643558773&refinements=p_27%3ARebecca+Siegel&s=books&sr=1-1

Is marijuana bad for your brain? Rebecca Siegel M.D. is the author of The Brain on Cannabis practices medicine in New York City psychiatrist specializing in adult, child and adolescent psychotherapy, psychopharmacology and a licensed prescriber of Medical Marijuana in NYS. She recently joined the Amen Clinics after more than 13 years in group and private practice settings. She currently studies the brain on cannabis reviewing scans of changes. Dr. Siegel graduated from Albert Einstein Medical School where her father also attended and specialized in Neurology. She completed her Psychiatry residency and Child & Adolescent fellowship at Mount Sinai Hospital in New York City. Dr. Siegel is supportive of a healthy lifestyle with nutrition, brain-directed supplements, sleep, and management of stress. Dr. Siegel has resided in NYC for more than 20 years. She has three daughters and a goldendoodle named Maggie. Dr. Siegel provides a wide range of services including: Medication evaluations and ongoing client management Short and long-term psychotherapy using cognitive-behavioral, psychodynamic and supportive approaches Coordination of interdisciplinary treatment plans with schools and other mental health professionals Learning Disabilities Asperger's and Autism Spectrum Disorder Family Planning, Pregnancy and Postpartum Issues Lectures for parent groups and schools on topics such as ADHD, mood and anxiety disorders. She was passionate about finding CBD (cannabis) products that really help with pain, also she is an independent reviewer of CBD (cannabis) at cbdgummiesforpain.org Learn more about how to get healthy and stay healthy here: https://www.VictoryHealthCenter.com CONNECT: Instagram: https://www.instagram.com/victoryhealthcenter/ @DrJakeParrish @victoryhealthcenter @victoryhealthradio @victoryhealthtv Facebook: https://www.facebook.com/victoryknoxville Podcast: https://www.victoryhealthradio.com CONTACT: info@victoryhealthcenter.com ttp://www.amenclinics.com/ https://www.brainmdhealth.com/ http://www.mybrainfitlife.com/ Like us on Facebook: https://www.facebook.com/AmenClinic Follow us on Twitter: https://twitter.com/Amen_Clinics Connect with us on LinkedIn: http://bit.ly/AmenClinicsLinkedIn

Rebecca Siegel, M.D.: “There needs to be more research [on marijuana] so physicians can either get behind it or not get behind it." Siegel, a psychiatrist and a licensed prescriber of medical marijuana in New York state, joins mbg co-CEO, Jason Wachob, to discuss how marijuana actually affects your brain, plus: - How to know if medical marijuana will work for you (01:32) - Is marijuana really a gateway drug? (08:06) - How men & women's brains react differently to marijuana (14:41) - Healthier "swaps" for marijuana (24:50) - How to know if you or someone you love is abusing marijuana (27:02) Referenced in the episode: - Find the podcast transcript here. - Siegel's book, The Brain On Cannabis. - King's College study on marijuana & psychosis. - Malcolm Gladwell's op-ed on marijuana. - Learn more about Cannabinoid Hyperemesis Syndrome. - Alex Berenson's book, Tell Your Children: The Truth About Marijuana, Mental Illness, and Violence. - Amen Clinics. Enjoy this episode! Whether it's an article or podcast, we want to know what we can do to help here at mindbodygreen. Let us know at: podcast@mindbodygreen.com.

Dr. Mohamed Salem, gastrointestinal medical oncologist at the Levine Cancer Institute at Atrium Health in North Carolina, tells guest host Dr. John Sweetenham, associate director of clinical affairs at the UT Southwestern Harold C. Simmons Comprehensive Cancer Center, about the disturbing rise of early-onset colorectal cancer, the impact of socioeconomic disparities on patient outcomes and potential interventions to improve detection.   Transcript Dr. John Sweetenham: Hello, I'm John Sweetenham, the associate director of Clinical Affairs at UT Southwestern Harold C. Simmons Comprehensive Cancer Center and guest host of the ASCO Daily News podcast today. I'm delighted to welcome Dr. Mohamed Salem, a gastrointestinal medical oncologist at the Levine Cancer Institute at Atrium Health in North Carolina. Dr. Salem is going to be discussing with us the disturbing rise in early onset colorectal cancer and the impact of socioeconomic disparities on patient outcomes and potential interventions to increase screening, particularly in younger populations. Mohamed, many thanks for joining us on the podcast today. Dr. Mohamed Salem: Thank you, Dr. Sweetenham for the kind invitation. And I have to tell you, I'm very grateful for this invitation to cover this topic. And also, thanks to the ASCO Daily News team for shedding the light on this. Dr. John Sweetenham: Great. Before we start, I should mention that my guest and I have no conflicts of interest relating to the topic today. Full disclosures of all guests on the ASCO Daily News podcast are available on our transcripts at ASCO.org/podcast. Mohamed, low socioeconomic status has been associated with worse survival in patients with colorectal cancer, otherwise known as CRC. But there hasn't been as much focus on the impact of socioeconomic status for those patients who have early onset colorectal cancer and, specifically, I guess, we mean by that, those patients who develop this condition in early adulthood. Of course, it's quite well known, generally, that adolescents and young adult patients who develop various types of cancer appear to have worse outcomes than both their childhood and their adult counterparts. Your study, published in The Oncologist, looked at the impact of sociodemographic disparities and insurance status on survival of patients with early onset colorectal cancer and, maybe not surprisingly, in some respects, based on experience in other diseases, demonstrated worse outcomes. Could you talk to us a little about the data in your study and how that might inform programs to improve early detection and treatment of patients with colorectal cancer? Dr. Mohamed Salem: Sure. As you mentioned, Dr. Sweetenham, there are two problems. A socioeconomic problem, which is, by itself, a huge challenge we are facing as a community. On the other hand, two, this colorectal cancer problem in younger adults is another issue that we have been facing now for maybe a decade or two. Rebecca Siegel just published a paper a couple of years ago showed that the increased incidence of [colorectal] cancer in adults, it's on the rise. And it brings many challenges to this population in terms of the diagnosis, their care, and their outcome. But when you couple this with the challenge that socioeconomic status impact on the outcome of our patient, this becomes a very, very complicated problem. So, our group wanted to look not only on the impact of socioeconomic status, but the impact on that problem on patients with early onset colorectal cancer and see how complicated this will be to their outcome. We examined more than 30,000 patients, and we chose the cutoff [at age] 40. Early onset definition could vary a little bit, so you have 40, you have 45, some people think even 50, but we choose 40 just because we wanted to focus on the very young group. We utilized National Cancer Database and we obviously thank them for giving us access to this data. And we tried to look at the impact of socioeconomic status, and it was stunning. We found that survival decreased with the decrease of socioeconomic status. So, the patient who carried the best survival was those with highest socioeconomic status and then the lower SES goes, the worse is their survival outcomes. And also, not just survival. We found that if you have low socioeconomic status, you are more likely to have stage III or IV tumors, which is, as you know, more advanced cancer, you're more likely to have node-positive disease, and also, you're more likely to present with stage IV colon cancer. So, just to highlight how impactful the socioeconomic status or factor in the presentation in disease and the outcome, and not only this one. We will also looked at insurance status. It was very clear that patients with no insurance or Medicaid, they do much worse. They had the higher risk of mortality compared to patients with commercial private insurance. And you have to wonder having this issue with being young adult and having a cancer and then having no insurance, have no means to access care. That's something, as you mentioned, perhaps we could, as a community, look into it and try to remove those barriers, to hopefully improve the patient outcome. Dr. John Sweetenham: Yeah, one of the things that struck me from looking at your paper was the fact that stage to stage, age for age. If patients had insurance, it did mediate some of the adverse prognostic effects of socioeconomic status, if I read the paper correctly, which does suggest to me that part of the problem at least is access to care. Would you agree with that? Dr. Mohamed Salem: I totally agree, 100%. And it's also interesting that we even looked at multiple angles. We looked at uninsured, by itself. We looked at Medicaid insurance. We looked at private versus not private. And it doesn't matter how we look at it, and adjusting for all other co-founders and stage, insurance status played a significant role on the impact of survival for those patients. Dr. John Sweetenham: Very interesting that I think that there are several other studies in other diseases which are beginning to show very similar emerging patterns. Just moving on from that a little, I think remarkable numbers that stood out from the studies which you cite in your article in The Oncologist is that 2015 study by Bailey et al. which was predicting that, by 2030, the incidence rates will have increased really quite substantially. And for the younger age group, those aged 20 to 34, the estimate was at a 90% increase in incidence. And for those in the 35 to 49 year age group, the suggestion was that incidence rates would increase by almost 28%, so I think there are a couple of questions that I have regarding that. The numbers are pretty sobering. Can you talk to us a little bit about what we know about the factors that are driving this increase in incidence? Dr. Mohamed Salem: Sure. I do agree with you, Dr. Sweetenham. I think this are very alarming numbers and very alarming phenomena. I'm sure you remember when we're in medical school and fellowship, we used to think colorectal cancer is a disease of older people. Unfortunately, now, we're seeing younger patients getting this. Not the age of 50 or 40 or 30 as you mentioned, even 20 years old. My youngest patient is 17-years-old. And it's not uncommon for me to see patients who are like 20-21 years old coming with this disease. There are many risk factors for colorectal cancer, as you know, obesity, diabetes, tobacco, alcohol, exercise, and other genetics and hereditary reasons. But the truth is that many of those patients come to our clinic are fit. They eat well, they don't smoke, they don't drink, so it appears there is something else going on. And there are many theories going into this, but the truth is that we're actually not sure 100% what are the exact reason for that rise in incidence among young adults. Some people think microbiome might have a role here. Some people think obesity, as I mentioned, has more impact on younger people than older people, but I think also is this is an area of research now. And we hope they'll continue to look into this and try to identify the exact reason why this is happening. But I also wanted to touch base a little bit about an important issue, because the paper you cited, both the American Cancer Society and the task force took the screening or issued recommendations regarding the screening to be from [age] 50 to go now to 45. We used to have a screening recommendation at age of 50 for average risk. Now, as of 2018, the American Cancer Society said you should be screened at 45, and most recently, the task force said the same thing. However, if you think about it, our study looked at patients who are [age] 40. So, the change in the screening really is not going to impact them, because it's still not even at the age of screening and, therefore, education, outreach and educating our patients, our population about the risk and the symptoms and signs of this disease is extremely important  because it makes a huge difference if the cancer gets detected at stage I, which most of the prime surgery is enough and 99% of patients or more than 90% of patients would be cured and don't even need anything besides surgery, versus, as I mentioned, when they start to come into the office with stage IV disease. Now, it's a totally different story and totally different outcome. Dr. John Sweetenham: Yeah, and I guess one of the other questions, the whole screening strategy issue is obviously a very big issue right now and I guess somewhat controversial as well. But I think it's true to say, and if I'm wrong, I stand corrected, that in general, compliance with screening as a whole tends to diminish with age. So, I'm sure, for all kinds of reasons, many of which may be kind of socioeconomic, financially-related, younger individuals are less likely to get screened, either because of insurance or what other issues they may have. And so, I wonder as age goes down, and I'd make the assumption that it may be true, that compliance with screening protocols also goes down. It'll be interesting to speculate on what are going to be useful interventions, particularly in that very young age group, might lead to earlier detection of colorectal cancer in, let's say, a 22-year-old. It can be a difficult issue to unravel, I think. Dr. Mohamed Salem: I totally agree. I think it gets very complicated very quickly because, one, as you mentioned, access to care and coverage and being able to afford this is one issue. But also, if you think about it from logistics, younger people need to work. Maybe they have kids, they need to take care of them. They already have a busy schedule and busy life going on to begin with. So, for them, to take the time off and start to do this office visit takes away time from them, so it affects the compliance. So, hopefully, more awareness and more recognition and encouraging each other to take a day off and just go to get screened might actually result in life saving. Also, I would like to say something important. Most of us, as physicians, when we see an older patient with rectal bleeding, for example, we always think about, OK, maybe he has colon cancer, maybe she has colon cancer. But we don't think the same way when we see a 25 year-old old bleed. So, I think, as a family doctor or somebody who is a medical doctor that will actually seeing that patient, the threshold should be lowered for symptoms and also for early referral. And the other thing I would like to encourage your viewer is that none of us would be excited and happy to talk to their loved one or their friend about his or her old habits as having their rear bleeding, abdominal colics, or so on, and so forth. But sometimes, those symptoms are the symptoms because of colon cancer. I always say, you know your bodies are best, so if you thinks there's something wrong, don't be embarrassed to talk about that. You have to share those symptoms with your family doctor, or at least your loved one to get an advice and get evaluated. And this gets complicated among minorities, because somehow there is a shame in this. And I think looking for safe environment, community network, as you mentioned at the beginning, easy access to medical care is crucial. You're not going to be able to get screened if you don't have the bus ticket to get to the center to be screened there. The last thing I would just like to stress also, if I may, most people think a screening is connected to colonoscopy, which is partially true, but colonoscopy is not the only way patients can get screened. There are many, many other ways that people can get screened including stool tests that you can do at home and send it to your doctor. So, colonoscopy is not the only way you can get screened. You can also discuss with your family doctor or even loved one about other means that you can get screened. Dr. John Sweetenham: Yeah, I think that's a really important point, and it raises another question actually, which may be difficult to answer in this specific age group. But I just wonder, in general terms, whether you can make any comments about how much ground do you think we may have lost during the pandemic in terms of delayed screening and delayed diagnosis. Are you are you seeing evidence of that in the literature or in your own practice and your own institution now? Dr. Mohamed Salem: I think that's a pretty important question. I would say yes to both. Last year, there was data showing that colorectal cancer cases declined. All of us know nothing had change. I mean, the cases are the same out there. It's just not been diagnosed yet because most hospitals obviously, including ours, and many, many other hospitals throughout the country were trying to survive the COVID-19 pandemic, and that got a lot of patients to be delayed for screening. Many patients didn't feel comfortable going to the hospital to get either their colonoscopy or even to the family doctor visit, and so on, and so forth. So, I think this delay in the detection of the cancer. The cancer did not didn't appear. It just was not detected yet. And the risk of that, as I mentioned earlier, the more time passed without intervention, if someone has a cancer, that means more advanced stage. It goes from stage I to II and III and IV with time, and with that, the survival and outcomes get worse. So, that also brings another point that we think, it's that younger patient has more aggressive disease. I think there is some data about that. But also, I wonder if is this really more aggressive disease or just delayed in diagnosis. When you go to your family doctor or even get it checked then they say they're having rectal bleeding. This could be, yes, because of hemorrhoid, but also, it could be because of colon cancer. And I'm not saying everyone with rectal bleeding has colon cancer, but I'm saying that could be one of the reasons. And I would say you really have to seek medical advice if you have symptoms because, again, early detection is the best part about this, and it really saves lives and it changes a lot of things. So, yes, it's a pandemic. It had definitely, no doubt, impact on the colorectal cancer care. And I would predict is that we're going to start seeing more and more patients with more advanced disease in the coming months and years. Dr. John Sweetenham: Yeah, that's an alarming prediction. Of course, taken in conjunction with the other prediction that we mentioned earlier from the study by Bailey et al., it really should give us cause for concern. And I think, maybe my final question to you would be, given what you've just said, plus those data in somewhat dire predictions for 2030, what do we need to do now to prevent that prediction from Bailey et al. from coming true, do you think, if there's anything we can do at this stage? Dr. Mohamed Salem: I think that's a very complex question. But I think, the way I think about this, every one of us, as an individual and organization and even in government and political entity, we really have a role to play. As an individual, I would say, as I mentioned before, you know your body well, so I always say this phrase, 'If you feel something, say something.' This could be a life changing behavior. So, if you feel like there's something wrong with you, please don't be embarrassed to share this. Talk to your family doctor, talk to your friend, and seek medical advice. As a community, we have to encourage each other to share this information, to teach each other certain habits that might help early detection. And if you are at risk, please go ahead and get screened. As I mentioned, colonoscopy is one mean, but there are many others. As an institution, I think raising awareness is important. I think providing easy access to care, that's also very important. And from the government and political entity, I think looking at those people with diversity and disparity, and people with no insurance, people who need special support and need to get help, I think we should have a community program out there. Some help out there, whether this comes through insurance, means, or other programs that we need to look at. And I think this might have some impact on our ability to detect this cancer early on. I always say, which, I think maybe some people might think is an exaggerated statement, but no one really should die from colorectal cancer. Because again, if you detect the cancer early, minimal care should take care of that. The problem happens when we don't detect it early and the patient presents with stage III or IV disease. Dr. John Sweetenham: Yeah, so it's kind of a multifaceted approach, everything from the personal right through to the political aspect is involved in what we all need to do to contribute to this. So, I really appreciate your time today and sharing your insights, and congratulations on the study, which, I think, highlighted actually not just one, but several really important issues in this kind of growing incidence of colorectal cancer and what appeared to be growing disparities as well. Thanks so much for joining me on the podcast today. I hope that you continue to make an impact on these disturbing trends in the years to come. Dr. Mohamed Salem: Thank you, Dr. Sweetenham, for having me, and it's a pleasure to be with you tonight. Dr. John Sweetenham: And thank you also to our listeners for your time today. If you enjoyed this episode, please take a moment to rate and review us wherever you get your podcasts.   Disclosures:  Dr. John Sweetenham: None disclosed.  Dr. Mohamed Salem: Consulting or Advisory Role: Taiho Pharmaceutical, Exelixis, Bristol-Myers Squibb Speakers' Bureau: Genentech/Roche, Taiho Pharmaceutical   Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

In this series of mini audio guides, experts and insiders bring you the most important news, up-and-coming talent and local insights from the Frieze art fairs. Even if you can't be there in person, the creatives featured in this series will guide you around all the pulse points of interest and excitement in and around the fair. In this episode, Rebecca Siegel, director of Americas and content for Frieze Los Angeles, speaks to Jenny Schlenzka, executive artistic director at Performance Space New York. Originally from Berlin, she previously worked as a curator at the Museum of Modern Art, where she was responsible for launching the performance art department. Working as she does at the forefront of new artistic endeavours, Rebecca asks her about which up-and-coming artists and under-the-radar events to look out for at Frieze New York 2021.

In this series of mini audio guides, experts and insiders bring you the most important news, up-and-coming talent and local insights from the Frieze art fairs. Even if you can't be there in person, the creatives featured in this series will guide you around all the pulse points of interest and excitement in and around the fair. In this episode, Rebecca Siegel, director of Americas and content for Frieze Los Angeles, speaks to the Brooklyn-based painter Dana Lok. Her work experiments with different viewpoints and examines, among other things, the interplay between space and time. Her work has been shown in a number of exhibitions including the Fisher Landau Center for Art and the Judith Charles Gallery, as well as which she has received a number of awards and scholarships such as the Andrew Fisher Fellowship from Columbia University. Rebecca speaks to Dana about how she is involved with Frieze New York 2021 and how her art responds to the world today.

In this series of mini audio guides, experts and insiders bring you the most important news, up-and-coming talent and local insights from the Frieze art fairs. Even if you can't be there in person, the creatives featured in this series will guide you around all the pulse points of interest and excitement in and around the fair. In this episode, Rebecca Siegel, director of Americas and content for Frieze Los Angeles, speaks to Antwaun Sargent, the critic and author, who has recently been appointed as a director and curator for Gagosian. As a New Yorker with his ear to the ground, she finds out from him about the things to look out for outside of the fair – which art galleries, institutions and events we should be watching out for in and around Manhattan, and some of the things we can do if we can't be there in person.

In this series of mini audio guides, experts and insiders bring you the most important news, up-and-coming talent and local insights from the Frieze art fairs. Even if you can't be there in person, the creatives featured in this series will guide you around all the pulse points of interest and excitement in and around the fair. In this episode, Rebecca Siegel, director of Americas and content for Frieze Los Angeles, speaks to Kimberly Drew, the Brooklyn-based curator and writer who came to public consciousness with her Tumblr, Black Contemporary Art, where she built an audience of young, creative and socially minded fans. They discuss her involvement with the Vision and Justice project, and why it has evolved into the powerful political arts and culture platform it is today. She also shares her tips for how best to spend an afternoon enjoying art in New York.

So we've talked about relationships on here but how about the absence of relationships? As in... being UNBOYFRIENDABLE by choice? I get the 311 from my good friend Rebecca Siegel on what it's not the worst thing in the world to not be cuffed, how she's been just fine without a man (and thriving, I might add), and, of course, what it's like to put yourself out there after having not really done so to begin with. It's a good one.

Do you know a little girl who dreams of becoming an astronaut, a fighter pilot, or an aeronautical engineer? In this episode, we celebrate the achievements of women who dared to follow their own dreams at a time when they were laughed at and dismissed. First, host Suzanne McCabe talks with Rebecca Siegel, the author of To Fly Among the Stars: The Hidden Story of the Fight for Women Astronauts. Rebecca describes the early years of America's space program, when 13 brave women trained in a secret, privately-funded program, hoping to earn their spot among the stars. These accomplished air racers, test pilots, and flight instructors later lobbied the White House and Congress to have women included in the astronaut program. Rebecca's riveting tale about Jerrie Cobb, Janey Hart, and 11 other women serves as an inspiration for any girl who doubts that she can achieve whatever she sets her mind to. Suzanne also talks with Dr. Ronke Olabisi, an assistant professor of biomedical engineering at the University of California, Irvine. She tells listeners about her childhood dream of becoming an astronaut and how that led to her career as a biomedical engineer and inventor. Special Thanks: Music composer: Lucas Elliot Eberl Producer: Bridget Benjamin Associate Producer: Constance Gibs Sound engineer: Daniel Jordan Coming Soon: Honoring the Asian American Experience with Kelly Yang Music in Literature: Tami Charles and Lamar Giles

Rebecca Siegel, author of 'To Fly Among the Stars: The Hidden Story of the Flight for Women Astronauts,' joins us for a chat about the Mercury Program and the 13 women who went through astronaut training, but were not allowed to become astronauts. She also tells us about the process of how to make these complex, nuanced histories accessible to a younger audience.

To help you prepare for your PM&R Board Exams, we're bringing you a podcast series dedicated to current practices and core knowledge that you will be tested on. The AAP's Board Review podcasts are directed by Resident Physicians Margaret Beckwith, MD and Collin Byrne, MD, MSc. This episode was written, hosted and reviewed for accuracy by Emily Kivlehan, MD and Rebecca Siegel, MD. The objective of this episode is to improve knowledge of important pediatric milestones.

Space journalist Andrew Jones and his cat join the Space Boffins this month to discuss China's ambitious plans for the Moon and beyond. Sue Nelson and Richard Hollingham also talk to Nellie Offord from UK company SSTL about their lunar communications satellite (and whether it will go beep), hear from author Rebecca Siegel about the enormous egos of the Mercury astronauts and celebrate space chimp Ham. And should Space Boffins be renamed? You decide... Like this podcast? Please help us by supporting the Naked Scientists

Space journalist Andrew Jones and his cat join the Space Boffins this month to discuss China's ambitious plans for the Moon and beyond. Sue Nelson and Richard Hollingham also talk to Nellie Offord from UK company SSTL about their lunar communications satellite (and whether it will go beep), hear from author Rebecca Siegel about the enormous egos of the Mercury astronauts and celebrate space chimp Ham. And should Space Boffins be renamed? You decide... Like this podcast? Please help us by supporting the Naked Scientists

Space journalist Andrew Jones and his cat join the Space Boffins this month to discuss China's ambitious plans for the Moon and beyond. Sue Nelson and Richard Hollingham also talk to Nellie Offord from UK company SSTL about their lunar communications satellite (and whether it will go beep), hear from author Rebecca Siegel about the enormous egos of the Mercury astronauts and celebrate space chimp Ham. And should Space Boffins be renamed? You decide... Like this podcast? Please help us by supporting the Naked Scientists

Every year the American Cancer Society estimates the number of new cancer cases and deaths that will occur nationally and in each state. Published annually since 1951, “Cancer Facts & Figures” provides the most current information about cancer. These widely cited projections serve as a basis for research, are a valued resource by policymakers, and are also readily understood by the public. How many new cancer cases are there projected to be in 2021? What are the current cancer incidence, mortality, and survival statistics? What’s the latest information on cancer symptoms and risk factors? The just-released “Cancer Facts & Figures 2021” and “Cancer Statistics 2021” provide a comprehensive breakdown of the most up-to-date cancer statistics. This year’s report also includes a special section on cancer and COVID-19. To find Cancer Facts & Figures 2021, as well as slides and an interactive tool where you can dive deeper into the data, visit http://cancer.org/statistics Rebecca Siegel, MPH, is lead author of these publications. She is a cancer epidemiologist and Senior Scientific Director of Surveillance Research at the American Cancer Society. Ms. Siegel directs the production of 7 Facts & Figures publications and their accompanying scientific articles, including the Cancer Facts & Figures 2021, which was published January 12. Her other research focuses on disparities in cancer incidence and mortality with an emphasis on colorectal cancer, particularly early-onset disease. Her research contributed to a shift in the age at which the American Cancer Society recommends beginning colorectal cancer screening. 3:00 – Rebecca Siegel on Cancer Facts & Figures 2021 and Cancer Statistics 2021 4:54 – Where does this cancer data come from? 8:01 – The differences between Cancer Facts & Figures 2021 and Cancer Statistics 2021 10:30 – What makes these publications so important? 13:16 – On the importance of her team’s findings on early onset colorectal cancer, and how this research led to an update in guidelines on when to start screening 17:37 – Findings shared in the special section on COVID-19 and cancer 22:15 – On what findings surprised her in this year’s edition 24:47 – A hopeful takeaway from Cancer Facts & Figures 2021

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Ms Rebecca Siegel, Scientific Director of Surveillance Research at the American Cancer Society. Ms Rebecca Siegel is first author on the paper 'Global patterns and trends in colorectal cancer incidence in young adults' published in Gut in December 2019. Read the article - https://gut.bmj.com/content/68/12/2179

Support the show (https://www.patreon.com/10KDollarDay/)

CBD oil and medical marijuana is new to the scene, and therefore it doesn’t yet have sufficient research behind it to help you make the decision on whether or not it could help you. Fortunately, we have the next best thing, as brain health specialists Dr. Daniel Amen, Tana Amen, and Dr. Rebecca Siegel are here to answer your questions on medical marijuana and CBD use.

With all the conflicting information out there concerning the use of medical marijuana and CBD, it can be difficult to separate fact from fiction. In this episode, Dr. Daniel Amen and Tana Amen continue their discussion with Dr. Rebecca Siegel on all things CBD. This episode focuses on the health benefits of using CBD, as well as its side effects.

The debate rages on over whether doctors should be allowed to prescribe medical marijuana to their patients. But what does the science say on the matter? In this episode of The Brain Warrior’s Way Podcast, Dr. Daniel Amen and Tana Amen are again joined by Dr. Rebecca Siegel, this time to discuss what scientific studies have shown us about using CBD for certain treatments.

It’s one of the hottest topics in the medical community right now, but also one of the most controversial. So what exactly is CBD, and is it really a medical breakthrough, or just another bad habit? In this special series on CBD and medical marijuana, Dr. Daniel Amen and Tana Amen are joined by Dr. Rebecca Siegel for a discussion on the many pros and cons of using CBD as a treatment option.

This episode will talk all about the upcoming renovations at Elm Middle School and features Ms. Rebecca Siegel, Principal at Elm, and Ms. Ashley Groeneveld, Assistant Principal.

On the season finale of Hidden Noise, hosts Abby Sandler and Rebecca Siegel head to the Neue Galerie for “Before the Fall: German and Austrian Art of the 1930’s.” Then, to close out the season the hosts will be joined by two distinguished guests for the Even 8: JiaJia Fei from the Jewish Museum and […] The post Hidden Noise: Episode no. 14 appeared first on Even Magazine.

On episode 13 of Hidden Noise, hosts Abby Sandler and Rebecca Siegel visit the Met Breuer for this week’s Go See: “Like Life: Sculpture, Color, and the Body (1300-now).” Then the hosts are joined by Peter Russo, director of Triple Canopy for the Even 8. The post Hidden Noise: Episode no. 13 appeared first on Even Magazine.

  On episode 12 of Hidden Noise, hosts Abby Sandler and Rebecca Siegel head to the Whitney for “Grant Wood: American Gothic and Other Fables” and “Zoe Leonard: Survey.” The hosts are then joined by Emma Enderby, curator at The Shed, to discuss the forthcoming programming at the eagerly anticipated institution. The post Hidden Noise: Episode no. 12 appeared first on Even Magazine.

On episode 11 of Hidden Noise, hosts Abby Sandler and Rebecca Siegel head to MoMA for “Tarsila do Amaral: Inventing Modern Art in Brazil.” For Critical Conversations, Even editor Jason Farago is joined by artist Sean Landers to discuss his current exhibition at Petzel Gallery. The post Hidden Noise: Episode no. 11 appeared first on Even Magazine.

For episode 10 of Hidden Noise, hosts Abby Sandler and Rebecca Siegel round up the top four New York City art fairs you should visit this week. In addition to covering the fairs, the hosts are joined by Eater editor Stefanie Tuder who shares her food and drink recommendations to keep you going along the […] The post Hidden Noise: Episode no. 10 appeared first on Even Magazine.

  On episode 9 of Hidden Noise, hosts Abby Sandler and Rebecca Siegel discuss this weeks Go See: “Peter Hujar: Speed of Life” at the Morgan Library and Museum. In Critical Conversations, Even editor Jason Farago speaks to painter Amy Sillman. For the Even 8, the hosts are joined by The Kitchen’s executive director and […] The post Hidden Noise: Episode No. 9 appeared first on Even Magazine.

On episode 8 of Hidden Noise, roles are reversed and host Abby Sandler welcomes Even publisher and co-host Rebecca Siegel and Even editor Jason Farago to the studio to discuss issue 9, which hits stands next week. From the contents of the issue, to the structure of the magazine, Jason and Rebecca give a behind […] The post Hidden Noise: Episode No. 8 appeared first on Even Magazine.

On episode 7 of Hidden Noise, hosts Abby Sandler and Rebecca Siegel venture up to 125th Street for “Arthur Mitchell: Harlem’s Ballet Trailblazer,” on view at the Miriam and Ira D. Wallach Gallery, now located in Columbia University’s Lenfest Center for the Arts. Then, Artadia director Carolyn Ramo joins the hosts to discuss the non-profit […] The post Hidden Noise: Episode no. 7 appeared first on Even Magazine.

As an improv teacher, Rebecca Siegel focuses on teaching her students to listen. Since improv is a highly reactive performance, you have to know not just what people are saying, but how and why they're saying it. In this episode, Rebecca draws some amazing comparisons between the world of improv comedy (which she’s been doing for 17 years) and loving people in everyday life.

Today's guests are an inspiration. Amidst all the bad news we're bombarded with each day, it's uplifting to hear from people who have sacrificed to help others in danger. Rebecca Siegel and Ariella Applebaum are American college students who have spent many months in Israel, as volunteer medics for Magen David Adom, the emergency ambulance service that saves lives of people of all faiths. Their stay included service during Operation Protective Edge. As you can hear in their voices, they not only helped others, but were moved themselves, after these life changing experiences, to fill shoes bigger than they'd ever dreamed. Erik Levis, Communications Director for American Friends of Magen David Adom, describes this overseas volunteer program and the invaluable work of MDA.